Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

BioScience Health Innovations (BHIC) Profit After Tax (2020 - 2025)

BioScience Health Innovations (BHIC) has disclosed Profit After Tax for 6 consecutive years, with -$233630.0 as the latest value for Q4 2025.

  • Quarterly Profit After Tax fell 2446.39% to -$233630.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $642090.0 through Dec 2025, up 638.03% year-over-year, with the annual reading at $642090.0 for FY2025, 638.03% up from the prior year.
  • Profit After Tax for Q4 2025 was -$233630.0 at BioScience Health Innovations, down from -$8782.0 in the prior quarter.
  • The five-year high for Profit After Tax was $457704.0 in Q2 2025, with the low at -$233630.0 in Q4 2025.
  • Average Profit After Tax over 5 years is $17271.6, with a median of -$13378.5 recorded in 2021.
  • Peak annual rise in Profit After Tax hit 899.53% in 2025, while the deepest fall reached 2446.39% in 2025.
  • Over 5 years, Profit After Tax stood at -$14089.0 in 2021, then plummeted by 105.25% to -$28917.0 in 2022, then tumbled by 32.71% to -$38376.0 in 2023, then soared by 125.95% to $9957.0 in 2024, then crashed by 2446.39% to -$233630.0 in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods came in at -$233630.0, -$8782.0, and $457704.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.